Obtainment of 177Lu-DOTA-LANREOTIDE for in vivo studies

被引：0
|
作者：
Nevares, Noemi
Jimenez, Yarissa Villareal
Deluca, Gustavo
Zapata, Miguel
Perez, Juan
Rojo, Ana
Crudo, Jose L.
机构：
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
10.1016/j.nucmedbio.2010.04.074
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：697 / 697
页数：1
相关论文
共 50 条
  • [41] A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
    Pavel, M. E.
    Ferone, D.
    Halperin, D.
    Myrehaug, S.
    Herrmann, K.
    Kunz, P. L.
    Chasen, B.
    Castillon, J. Capdevila
    Tafuto, S.
    Oh, D-Y.
    Yoo, C.
    Falk, S.
    Halfdanarson, T. R.
    Folitar, I.
    Zhang, Y.
    de Herder, W. W.
    Singh, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S753 - S753
  • [42] Measurement of reaction kinetics of [177Lu]Lu-DOTA-TATE using a microfluidic system
    Liu, Z.
    Schaap, K. S.
    Ballemans, L.
    de Zanger, R.
    de Blois, E.
    Rohde, M.
    Oehlke, E.
    DALTON TRANSACTIONS, 2017, 46 (42) : 14669 - 14676
  • [43] Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
    Teresa Monserrat Fuertes
    Borja Santos Zorrozua
    Emilia Rodeño Ortiz de Zarate
    Miguel Ángel Peinado Montes
    Carmen Vigil Díaz
    Pablo Mínguez Gabiña
    EJNMMI Physics, 10
  • [44] Description of an imaging protocol in patients with glioblastoma treated with [177Lu]Lu-DOTA-TATE.
    Canete, E. Cordoba
    Vivancos, M. Caballero
    Corredera, N. Gonzalez
    Ibanez, E. Trivino
    Sanchez, R. Sanchez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S209 - S209
  • [45] Kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy based on multiple small VOIs
    Kapidzic, Selma Curkic
    Gustafsson, Johan
    Larsson, Erik
    Jessen, Lovisa
    Gleisner, Katarina Sjogreen
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 120
  • [46] Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
    Fuertes, Teresa Monserrat
    Zorrozua, Borja Santos
    de Zarate, Emilia Rodeno Ortiz
    Montes, Miguel Angel Peinado
    Diaz, Carmen Vigil
    Gabina, Pablo Minguez
    EJNMMI PHYSICS, 2023, 10 (01)
  • [47] Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with chemotherapy
    Terry, S.
    Zink, J.
    O'Neill, E.
    Cornelissen, B.
    Nonnekens, J.
    Livieratos, L.
    Cheng, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S14 - S14
  • [48] Radioactivity levels in the saliva of patients undergoing targeted radioligand therapy with [177Lu]Lu-PSMA-I&T and [177Lu]Lu-DOTA-TOC
    Christian Schedeit
    Nasir Gözlügöl
    Radi Saiyed Alsheikh
    Mohamed Shelan
    Robert Seifert
    Federico Caobelli
    Urs Borner
    Tateyuki Iizuka
    Benoît Schaller
    Axel Rominger
    Paul Cumming
    Ali Afshar-Oromieh
    Konstantinos G. Zeimpekis
    Clinical Oral Investigations, 29 (5)
  • [49] Octreotate Lu 177 DOTA Tyr 3Nephrotoxicity: case report
    Reactions Weekly, 2017, 1666 (1) : 229 - 229
  • [50] Octreotate-Lu-177-DOTA-Tyr-3Thrombocytopenia: case report
    Reactions Weekly, 2017, 1680 (1) : 263 - 263
12345